Moores Cancer Center ( Site 0116)
La Jolla, California 92093-0698
0 studies enrolling now · 1 studies all time
What they study most
Melanoma
Studies at this site
A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)
— Completed